HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Kidney and haemostasis. A (personal) time-journey.

AbstractUNLABELLED:
Renal insufficiency is characterized by thrombocytopathy, caused by the accumulation of water soluble and protein bound waste products of protein metabolism, which are not adequately eliminated by the kidney. The kidneys also excrete drugs and their metabolites, which accumulate if dosages are not adjusted to the renal function and may cause clinically relevant bleeding (i. e. synthetic penicillins, vitamin K antagonists, new oral anticoagulants). Therefore, each patients kidney function (GFR) ought to be evaluated by the KDIGO guidelines. The survival of chronic renal patients is lowered by increasing cardiovascular complications. Particularly frequent is non-valvular atrial fibrillation. The recommended prophylaxis with vitamin K antagonists for renal insufficiency is hampered by increased bleeding as well as by augmented (coronary) vascular and valvular calcification. It is not known yet whether prophylaxis with vitamin K may prevent this complication.
CONCLUSION:
Because new oral anticoagulants are equally or even more effective and cause less bleeding, they may be favoured in future and even in end-stage renal failure if more is known about dosing, safety and efficacy. The measurement of serum FGF 23 concentration may be helpful as a marker for their use.
AuthorsK Andrassy
JournalHamostaseologie (Hamostaseologie) Vol. 35 Issue 1 Pg. 73-6 ( 2015) ISSN: 2567-5761 [Electronic] Germany
PMID25366713 (Publication Type: Journal Article, Review)
Chemical References
  • Anticoagulants
  • FGF23 protein, human
  • Fibrinolytic Agents
  • Fibroblast Growth Factor-23
Topics
  • Anticoagulants (administration & dosage, adverse effects)
  • Dose-Response Relationship, Drug
  • Fibrinolytic Agents (administration & dosage, adverse effects)
  • Fibroblast Growth Factor-23
  • Hemostasis
  • Humans
  • Kidney Function Tests (methods)
  • Renal Insufficiency, Chronic (chemically induced, diagnosis, physiopathology)
  • Risk Assessment
  • Thrombosis (complications, drug therapy, physiopathology)
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: